TITLE
A 3'-UTR KRAS-variant is associated with cisplatin resistance in patients with recurrent and/or metastatic head and neck squamous cell carcinoma.

ORGANISM
Homo sapiens

SUMMARY
To determine the differential expression of KRAS-variant HNSCC (head and neck squamous cell carcinoma) cell lines.

DESIGN
Total RNA collected from a panel of HNSCC cell lines.

